Nachrichten zur Astellas Pharma Inc. Aktie

Sandoz To Acquire Antifungal Agent Mycamine From Astellas Pharma

BASEL (dpa-AFX) - Sandoz said it has entered into an agreement to acquire worldwide product rights for systemic antifungal agent…

Astellas Transfers MYCAMINE® Product Worldwide

TOKYO, Jan. 23, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced…

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio

Basel, January 24, 2023 – Sandoz, the global leader in off-patent (generic and biosimilar) medicines, has signed an agreement to…

Astellas Pharma: FDA Lifts Clinical Hold On Trial Of AT845 In Late-Onset Pompe Disease

TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) said Friday that the U.S. Food and Drug Administration has lifted the…

Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease

TOKYO, Jan. 20, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced…

Leap rebounds as Astellas posts Phase 3 data for rival cancer candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas Receives SBTi Approval for Revised Science-Based Climate Goals to Reduce Greenhouse Gas Emissions

TOKYO, Jan. 19, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced…

Antibiotics market to grow by 5.11% Y-O-Y from 2022 to 2023: Rising prevalence of infectious diseases will drive growth - Technavio

NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Antibiotics market insights - Vendors: 15+, Including Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals…

Selecta Biosciences stock rises 10% on license deal with Astellas for Xork

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Selecta Biosciences Shares Rise 11% After Licensing Deal With Astellas Pharma

Selecta Biosciences Shares Rise 11% After Licensing Deal With Astellas Pharma...…

Astellas, Twist Bioscience team up for discovering antibodies for multiple targets

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease

Next-generation IgG protease candidate Xork to be licensed for development with AT845, an investigational Astellas Gene Therapies product, for the…

Basilea erhält dank guter Cresemba-Umsätze Meilensteinzahlung von Astellas

Pharma - Basilea erhält eine Meilensteinzahlung vom Partner Astellas....…

Continued strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 20 million sales milestone payment to Basilea

Ad hoc announcement pursuant to Art. 53 LR...…

Fortgesetzt gute Cresemba® (Isavuconazol)-Verkaufszahlen von Astellas in den USA lösen CHF 20 Mio. Umsatzmeilensteinzahlung an Basilea aus

Ad hoc-Mitteilung gemäss Art. 53 KR...…

Astellas Pharma, Eisai, Daiichi Sankyo and Takeda join hands to reduce environmental burden in the field of pharmaceutical packaging

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas, 3 Other Companies Collaborate To Reduce Environmental Burden In Field Of Pharma Packaging

TOKYO (dpa-AFX) - Astellas Pharma Inc., Eisai Co., Ltd., Daiichi Sankyo Co. and Takeda Pharmaceutical Company Limited. (TAK) said that…

Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging

TOKYO and OSAKA, Japan, Dec. 21, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, "Astellas"),…

Merck, Seagen, Astellas combo bladder cancer treatment sBLAs accepted by FDA

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas: PADCEV, KEYTRUDA Granted Priority Review In Treatment Of Metastatic Urothelial Cancer

KENILWORTH (NJ) (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY), Seagen Inc. (SGEN) and Merck (MRK) announced the FDA has accepted…

Astellas zolbetuximab shows survival benefit, meets main goal in 2nd gastric cancer trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas Announces Positive Results From Phase 3 Trial Of Zolbetuximab Combination In Gastric Cancer

TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) announced positive results from the Phase 3 GLOW clinical trial evaluating the…

The Astellas Global Health Foundation Provides $3.9 Million in Funding to Five Organizations, Supporting Key Access to Health and Community Resilience Efforts in Seven Countries

Grants to Americares, AMPATH Kenya, Amref, Sightsavers Inc. and USA for UNHCR are expected to impact nearly 2.7 million lives…

Astellas and MBC BioLabs Announce 2022 Future Innovator Prize Awarded to Bespoke Biotherapeutics and Cellinfinity Bio

Both Companies win a year of access to a prestigious life-science incubator in San Francisco, CA and to Astellas expertise…

Cancer Monoclonal Antibodies Market: Growth Opportunities led by Amgen Inc. and Astellas Pharma Inc. - Technavio

NEW YORK, Nov. 29, 2022 /PRNewswire/ -- The cancer monoclonal antibodies market report is a comprehensive research that provides in-depth…

Pharmaforschung: Krebsmittel der Biontech-Gründer überzeugt in Studie

Özlem Türeci und Ugur Sahin hatten den Wirkstoff mit ihrem Unternehmen Ganymed erforscht. Der japanische Pharmakonzern Astellas hat das Magenkrebs-Mittel…

Astellas Pharma Reports Higher H1 Profit And Sales; Ups Sales Guidance

TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY) Monday reported profit before tax of 120.48 billion yen for the first six…

Taysha Gene stock soars 36% as Astellas to pick 15% stake for $50M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Taysha Gene Therapies Shares Soar Premarket on Astellas Investment >TSHA

Taysha Gene Therapies Shares Soar Premarket on Astellas Investment >TSHA...…

Astellas to Present Findings from Phase 3 Long-Term Safety Study of Fezolinetant in Oral Session at The North American Menopause Society 2022 Annual Meeting

SKYLIGHT 4™ study results demonstrate the 52-week safety and tolerability of fezolinetant 30 mg and 45 mg once daily Pooled…

Astellas, Pantherna expand collaboration on mRNA-based regenerative medicine programs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas and Pantherna Enter into a New Technology Evaluation Agreement for Research with Expanded Target Organ to Generate mRNA-Based Regenerative Medicine Programs Using Direct Reprogramming

TOKYO and HENNIGSDORF, Germany, Oct. 3, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas")…

dpa-AFX ProFeed